Koya Keizo

Sr. VP, Drug Development at MDGL

Sold, on record
$244k
Dollars the filings state
Form 4 sales
3
Latest Mar 1, 2012
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MDGLMADRIGAL PHARMACEUTICALS, INC.Sr. VP, Drug Development

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MDGLUnusual
    Mar 1, 2011 2011

    Sold 18,270 shares at $5.23 ($96k)

    Koya Keizo, Sr. VP, Drug Development

    Sold 35.6% of holdings ($268k position)32,999 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MDGLUnusual
    Apr 25, 2011 +55 days

    Sold 20,000 shares at $5.80 ($116k)

    Koya Keizo, Sr. VP, Drug Development

    Sold 50.2% of holdings ($231k position)19,843 shares leftFiling

  3. 3 Form 4 sale MDGLUnusual
    Mar 1, 2012 +311 days

    Sold 6,844 shares at $4.70 ($32k)

    Koya Keizo, Sr. VP, Drug Development

    Sold 34.5% of holdings ($93k position)12,999 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Koya Keizo
Source
Mar 1, 2012Mar 5, 2012MDGLSr. VP, Drug DevelopmentForm 4 sale6,844$32k34.5%UnusualSEC
Apr 25, 2011Apr 26, 2011MDGLSr. VP, Drug DevelopmentForm 4 sale20,000$116k50.2%UnusualSEC
Mar 1, 2011Mar 3, 2011MDGLSr. VP, Drug DevelopmentForm 4 sale18,270$96k35.6%UnusualSEC